APVO-210

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAPVO-210

Drug Alias NameAPVO-210ES-210

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 86 inhibitorsInterleukin 10 receptor inhibitors

TargetsCluster of differentiation 86Interleukin 10 receptor

Therapy Area/IndicationsPsoriasisColitis, Ulcerative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAptevo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAptevo

Active IndicationsN/A

Inactive IndicationsPsoriasisColitis, Ulcerative

Other Information

ATC CodeN/A